Opus Point Partners Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Opus Point Partners Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,000	Closed	-$4.15M	–	74
2015 Q1	$4.15M	Buy	24,000 +5,813	+32%	+$853K	3.48%	3
2014 Q4	$2.09M	Buy	+18,187	New	+$2.2M	2.07%	23

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Opus Point Partners Management's SLXP Position: Q2 2015 in Review

Opus Point Partners Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 24,000 shares — an estimated $4.15M sold.

Opus Point Partners Management first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $4.15M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Opus Point Partners Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Opus Point Partners Management sold 24,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $4.15M.
Opus Point Partners Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
Opus Point Partners Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $4.15M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Opus Point Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.